https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&id=29447268&retmode=xml&tool=Litmetric&email=readroberts32@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09 294472682018052320181113
1932-62031322018PloS onePLoS OneCirculating small non-coding RNAs reflect IFN status and B cell hyperactivity in patients with primary Sjögren's syndrome.e0193157e0193157e019315710.1371/journal.pone.0193157Considering the important role of miRNAs in the regulation of post-transcriptional expression of target genes, we investigated circulating small non-coding RNAs (snc)RNA levels in patients with primary Sjögren's syndrome (pSS). In addition we assessed if serum sncRNA levels can be used to differentiate patients with specific disease features.Serum RNA was isolated from 37 pSS patients as well as 21 patients with incomplete Sjögren's Syndrome (iSS) and 17 healthy controls (HC) allocated to two independent cohorts: discovery and validation. OpenArray profiling of 758 sncRNAs was performed in the discovery cohort. Selected sncRNAs were measured in the validation cohort using single-assay RT-qPCR. In addition, unsupervised hierarchical clustering was performed within the pSS group.Ten sncRNAs were differentially expressed between the groups in the array. In the validation cohort, we confirmed the increased expression of U6-snRNA and miR-661 in the iSS group as compared to HC. We were unable to validate differential expression of any miRNAs in the pSS group. However, within this group several miRNAs correlated with laboratory parameters. Unsupervised clustering distinguished three clusters of pSS patients. Patients in one cluster showed significantly higher serum IgG, prevalence of anti-SSB autoantibodies, IFN-score, and decreased leukocyte counts compared to the two other clusters.We were unable to identify any serum sncRNAs with differential expression in pSS patients. However, we show that circulating miRNA levels are associated with disease parameters in pSS patients and can be used to distinguish pSS patients with more severe B cell hyperactivity. As several of these miRNAs are implicated in the regulation of B cells, they may play a role in the perpetuation of the disease.LopesAna PAP0000-0003-4954-5151Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.HillenMaarten RMRDepartment of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.ChouriEleniEDepartment of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.BloklandSofie L MSLMDepartment of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.BekkerCornelis P JCPJDepartment of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.KruizeAike AAADepartment of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.RossatoMarziaMLaboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.Functional Genomics Center, University of Verona, Verona, Italy.van RoonJoel A GJAGDepartment of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.RadstakeTimothy R D JTRDJDepartment of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.engJournal ArticleResearch Support, Non-U.S. Gov't20180215
United StatesPLoS One1012850811932-62030Autoantibodies0Immunoglobulin G0RNA, Small Untranslated9008-11-1InterferonsIMAdultAgedAutoantibodiesbloodB-LymphocytesimmunologyFemaleHumansImmunoglobulin GbloodInterferonsbloodMaleMiddle AgedRNA, Small UntranslatedbloodSjogren's SyndromebloodimmunologyYoung AdultCompeting Interests: The authors have declared that no competing interests exist.
201710172018242018216602018216602018524602018215epublish29447268PMC581405410.1371/journal.pone.0193157PONE-D-17-37190Nocturne G, Mariette X. Advances in understanding the pathogenesis of primary Sjogren's syndrome. Nat Rev Rheumatol. 2013;9:544–56. doi: 10.1038/nrrheum.2013.110 10.1038/nrrheum.2013.11023857130Dong L, Chen Y, Masaki Y, Okazaki T, Umehara H. Possible Mechanisms of Lymphoma Development in Sjogren's Syndrome. Curr Immunol Rev. 2013;9:13–22. doi: 10.2174/1573395511309010003 10.2174/1573395511309010003PMC370695423853604Holdgate N, St Clair EW. Recent advances in primary Sjogren's syndrome. F1000Res. 2016;5.PMC491698627347394Konsta OD, Thabet Y, Le Dantec C, Brooks WH, Tzioufas AG, Pers JO, et al. The contribution of epigenetics in Sjogren's Syndrome. Front Genet. 2014;5:71 doi: 10.3389/fgene.2014.00071 10.3389/fgene.2014.00071PMC398205024765104Sayed D, Abdellatif M. MicroRNAs in development and disease. Physiol Rev. 2011;91:827–87. doi: 10.1152/physrev.00006.2010 10.1152/physrev.00006.201021742789Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, et al. Serum microRNAs are promising novel biomarkers. PLoS One. 2008;3:e3148 doi: 10.1371/journal.pone.0003148 10.1371/journal.pone.0003148PMC251978918773077Wang J, Chen J, Sen S. MicroRNA as Biomarkers and Diagnostics. J Cell Physiol. 2016;231:25–30. doi: 10.1002/jcp.25056 10.1002/jcp.25056PMC877633026031493Macfarlane LA, Murphy PR. MicroRNA: Biogenesis, Function and Role in Cancer. Curr Genomics. 2010;11:537–61. doi: 10.2174/138920210793175895 10.2174/138920210793175895PMC304831621532838Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol. 2005;6:376–85. doi: 10.1038/nrm1644 10.1038/nrm164415852042Hu R, O'Connell RM. MicroRNA control in the development of systemic autoimmunity. Arthritis Res Ther. 2013;15:202 doi: 10.1186/ar4131 10.1186/ar4131PMC367278723379780Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–33. doi: 10.1016/j.cell.2009.01.002 10.1016/j.cell.2009.01.002PMC379489619167326Qu Z, Li W, Fu B. MicroRNAs in autoimmune diseases. Biomed Res Int. 2014;2014:527895 doi: 10.1155/2014/527895 10.1155/2014/527895PMC406565424991561Chen JQ, Papp G, Szodoray P, Zeher M. The role of microRNAs in the pathogenesis of autoimmune diseases. Autoimmun Rev. 2016;15:1171–80. doi: 10.1016/j.autrev.2016.09.003 10.1016/j.autrev.2016.09.00327639156Williams AE, Choi K, Chan AL, Lee YJ, Reeves WH, Bubb MR, et al. Sjogren's syndrome-associated microRNAs in CD14(+) monocytes unveils targeted TGFbeta signaling. Arthritis Res Ther. 2016;18:95 doi: 10.1186/s13075-016-0987-0 10.1186/s13075-016-0987-0PMC485589927142093Alevizos I, Alexander S, Turner RJ, Illei GG. MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjogren's syndrome. Arthritis Rheum. 2011;63:535–44. doi: 10.1002/art.30131 10.1002/art.30131PMC365329521280008Gourzi VC, Kapsogeorgou EK, Kyriakidis NC, Tzioufas AG. Study of microRNAs (miRNAs) that are predicted to target the autoantigens Ro/SSA and La/SSB in primary Sjogren's Syndrome. Clin Exp Immunol. 2015;182:14–22. doi: 10.1111/cei.12664 10.1111/cei.12664PMC457850426201309Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK, Calin GA. MicroRNAs in body fluids—the mix of hormones and biomarkers. Nat Rev Clin Oncol. 2011;8:467–77. doi: 10.1038/nrclinonc.2011.76 10.1038/nrclinonc.2011.76PMC342322421647195Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8. doi: 10.1136/ard.61.6.554 10.1136/ard.61.6.554PMC175413712006334Cuppen BV, Rossato M, Fritsch-Stork RD, Concepcion AN, Schenk Y, Bijlsma JW, et al. Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis? Arthritis Res Ther. 2016;18:189 doi: 10.1186/s13075-016-1085-z 10.1186/s13075-016-1085-zPMC499773127558398Mestdagh P, Van Vlierberghe P, De Weer A, Muth D, Westermann F, Speleman F, et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 2009;10:R64 doi: 10.1186/gb-2009-10-6-r64 10.1186/gb-2009-10-6-r64PMC271849819531210Marabita F, de Candia P, Torri A, Tegner J, Abrignani S, Rossi RL. Normalization of circulating microRNA expression data obtained by quantitative real-time RT-PCR. Brief Bioinform. 2016;17:204–12. doi: 10.1093/bib/bbv056 10.1093/bib/bbv056PMC479389626238539Brkic Z, Maria NI, van Helden-Meeuwsen CG, van de Merwe JP, van Daele PL, Dalm VA, et al. Prevalence of interferon type I signature in CD14 monocytes of patients with Sjogren's syndrome and association with disease activity and BAFF gene expression. Ann Rheum Dis. 2013;72:728–35. doi: 10.1136/annrheumdis-2012-201381 10.1136/annrheumdis-2012-201381PMC361868322736090Schwarzenbach H, da Silva AM, Calin G, Pantel K. Data Normalization Strategies for MicroRNA Quantification. Clin Chem. 2015;61:1333–42. doi: 10.1373/clinchem.2015.239459 10.1373/clinchem.2015.239459PMC489063026408530Bockmeyer CL, Sauberlich K, Wittig J, Esser M, Roeder SS, Vester U, et al. Comparison of different normalization strategies for the analysis of glomerular microRNAs in IgA nephropathy. Sci Rep. 2016;6:31992 doi: 10.1038/srep31992 10.1038/srep31992PMC499559027553688Cheng HH, Yi HS, Kim Y, Kroh EM, Chien JW, Eaton KD, et al. Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One. 2013;8:e64795 doi: 10.1371/journal.pone.0064795 10.1371/journal.pone.0064795PMC367641123762257Benz F, Roderburg C, Vargas Cardenas D, Vucur M, Gautheron J, Koch A, et al. U6 is unsuitable for normalization of serum miRNA levels in patients with sepsis or liver fibrosis. Exp Mol Med. 2013;45:e42 doi: 10.1038/emm.2013.81 10.1038/emm.2013.81PMC378926624052167Brito-Zeron P, Acar-Denizli N, Zeher M, Rasmussen A, Seror R, Theander E, et al. Influence of geolocation and ethnicity on the phenotypic expression of primary Sjogren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjogren Project Consortium. Ann Rheum Dis. 2016.27899373Iqbal J, Shen Y, Liu Y, Fu K, Jaffe ES, Liu C, et al. Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis. Blood. 2012;119:4939–48. doi: 10.1182/blood-2011-07-370122 10.1182/blood-2011-07-370122PMC336789522490335Pritchard CC, Kroh E, Wood B, Arroyo JD, Dougherty KJ, Miyaji MM, et al. Blood cell origin of circulating microRNAs: a cautionary note for cancer biomarker studies. Cancer Prev Res (Phila). 2012;5:492–7.PMC418624322158052